Merck Sharp and Dohme NZ - Latest News [Page 2]
Medsafe Coxib Review
Tuesday, 22 February 2005, 10:45 pm | Merck Sharp and Dohme NZ
“We recognize that the cardiovascular safety of the coxib and NSAID classes is an important public health issue. The data suggest an increased cardiovascular risk vs. placebo is a class effect. At the present time it is unclear if the class of ... More >>
Merck Realigns Distribution In New Zealand
Friday, 17 September 2004, 5:02 pm | Merck Sharp and Dohme NZ
Merck Limited, the New Zealand operation of Merck KGaA, one of the world’s largest pharmaceutical, laboratory consumables and specialized chemical multinational manufacturers and suppliers, has terminated its agency agreement with Biolab Limited in New Zealand, ... More >>
New Cholesterol-Lowering Drugs Available
Tuesday, 8 June 2004, 4:09 pm | Merck Sharp and Dohme NZ
New Zealanders with high cholesterol will benefit from a new agreement signed between the Pharmaceutical Management Agency (PHARMAC) and pharmaceutical company Merck Sharp & Dohme New Zealand (MSD NZ). More >>